Atos falls 18% as embattled French IT companies weighs rescue specials set to result in ‘massive dilution’

Atos falls 18% as embattled French IT companies weighs rescue specials set to result in ‘massive dilution’


This photograph taken on April 26, 2024 exhibits the headquarters of the French multinational facts technology business ATOS in Bezons, in close proximity to Paris. (Photo by Ludovic MARIN / AFP) (Picture by LUDOVIC MARIN/AFP via Getty Illustrations or photos)

Ludovic Marin | Afp | Getty Pictures

Shares of the struggling French IT business Atos tumbled on Monday as the company weighs involving two rescue discounts each established to lead to “huge dilution” of current shareholders.

Atos was down 17.86% at 11:19 a.m. London time.

The two restructuring offers on the table are led by Czech billionaire Daniel Kretinsky and critical Atos shareholder David Layani. The corporation will make its selection by Wednesday.

“The implementation of the proposals will final result in all cases in a enormous dilution of the current shareholders of Atos SE,” Atos explained in a statement on Monday.

The corporation explained it was performing with money creditors to safe maximum assistance for one particular of the discounts by June 5, aiming to reach remaining settlement on restructuring in July.

Inventory Chart IconInventory chart icon

hide content

Atos

Kretinsky formerly carried out conversations with Atos about shopping for pieces of its small business, which collapsed. Layani’s IT consulting organization Onepoint held in excess of 11% of Atos’ share capital and voting legal rights as of December 2023, in accordance to their website.

The two proposals are the final two remaining in a months-prolonged process of Atos thinking of prospective restructuring offers. Four proposals experienced been posted on Atos’ site in May perhaps, such as from Kretinsky’s EP Fairness Investment decision in partnership with investment company Attestor Restricted, Layani’s Onepoint with investment decision company Butler Industries, Atos’ money creditors and U.S. personal equity company Bain Cash.

Bain Capital’s offer was turned down by Atos, it said, when the firm’s fiscal creditors joined forces with Layani.

The discounts arrive right after a string of unsuccessful talks about whole or partial acquisition of the Atos company. Airbus also held such discussions.

In April, Atos stated it experienced obtained a letter of intent from the French governing administration to possibly receive pieces of its small business. At the time, the organization reported a non-binding offer could be manufactured in early June. On Monday, Atos noted that because of diligence on the deal was still ongoing.

Atos retains various delicate contracts with French authorities and the country’s army. It is also managing details and cybersecurity for the Paris 2024 Olympic video games.

The business has been going through mounting monetary troubles for some time, which include soaring financial debt. At the conclusion of the 1st quarter, Atos’ net credit card debt stood at 3.9 billion euros ($4.2 billion), the firm mentioned in April.



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More